Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Edward J. Modestino"'
Autor:
Kenneth Blum, Thomas McLaughlin, Abdalla Bowirrat, Edward J. Modestino, David Baron, Luis Llanos Gomez, Mauro Ceccanti, Eric R. Braverman, Panayotis K. Thanos, Jean Lud Cadet, Igor Elman, Rajendra D. Badgaiyan, Rehan Jalali, Richard Green, Thomas A. Simpatico, Ashim Gupta, Mark S. Gold
Publikováno v:
Journal of Personalized Medicine, Vol 12, Iss 2, p 321 (2022)
Reward Deficiency Syndrome (RDS) encompasses many mental health disorders, including a wide range of addictions and compulsive and impulsive behaviors. Described as an octopus of behavioral dysfunction, RDS refers to abnormal behavior caused by a bre
Externí odkaz:
https://doaj.org/article/8310bcc355524a619d3edb2e8ba8dbf8
Autor:
Kenneth Blum, Shan Kazmi, Edward J. Modestino, Bill William Downs, Debasis Bagchi, David Baron, Thomas McLaughlin, Richard Green, Rehan Jalali, Panayotis K. Thanos, Igor Elman, Rajendra D. Badgaiyan, Abdalla Bowirrat, Mark S. Gold
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 3, p 212 (2021)
This article describes a unique therapeutic precision intervention, a formulation of enkephalinase inhibitors, enkephalin, and dopamine-releasing neuronutrients, to induce dopamine homeostasis for detoxification and treatment of individuals genetical
Externí odkaz:
https://doaj.org/article/99bd1ab02b6f4e399fe0e0202ba3eef0
Autor:
Abdalla Bowirrat, Marcello Febo, Bruce Steinberg, A. Kenison Roy, David Baron, Thomas McLaughlin, Rajendra D Badgaiyan, Kenneth Blum, Edward J Modestino, Marks S. Gold, Raymond Brewer
Publikováno v:
Curr Psychopharmacol
During Lucid Dreams, the dreamer is aware, experiences the dream as if fully awake, and may control the dream content. The dreamer can start, stop, and restart dreaming, depending on the nature and pleasantness of the dream. For patients with Reward
Autor:
Kenneth Blum, Bruce Steinberg, Marjorie C Gondré-Lewis, David Baron, Edward J Modestino, Rajendra D Badgaiyan, B William Downs, Debasis Bagchi, Raymond Brewer, Thomas McLaughlin, Abdalla Bowirrat, Mark Gold
Publikováno v:
Psychology Research and Behavior Management
This is a review of research on “Precision Behavioral Management” of substance use disorder (SUD). America is experiencing a high prevalence of substance use disorder, primarily involving legal and illegal opioid use. A 3000% increase in treatmen
Autor:
Rajendra D Badgaiyan, Abdalla Bowirrat, Thomas J. McLaughlin, Igor Elman, Panayotis K. Thanos, A. Kenison Roy, Kenneth Blum, Debasis Bagchi, David Baron, Edward J Modestino, B. William Downs, Raymond Brewer, Mark S. Gold
Publikováno v:
Current Psychopharmacology. 10:86-97
Introduction: Polymorphic gene variants, particularly the genetic determinants of low dopamine function (hypodopaminergia), are known to associate with Substance Use Disorder (SUD) and a predisposition to PTSD. Addiction research and molecular geneti
Autor:
Panayotis K. Thanos, David Baron, B. William Downs, Kenneth Blum, Mark S. Gold, Rajendra D. Badgaiyan, Philip Fynman, Edward J Modestino, Raymond Brewer, Jean Lud Cadet, Marjorie C Gondré–Lewis., Sampada Badgaiyan, Igor Elman, David E. Smith, Jessica Valdez Ponce, Mark Moran, Alexander Weingarten, Lisa Lott
Publikováno v:
Molecular Neurobiology
Millions of Americans experience pain daily. In 2017, opioid overdose claimed 64,000 lives increasing to 84,000 lives in 2020, resulting in a decrease in national life expectancy. Chronic opioid use results in dependency, drug tolerance, neuroadaptat
Autor:
Mark S. Gold, Raymond Brewer, Edward J Modestino, Brent Boyett, Mark Moran, Kenneth Blum, David Baron, Rajendra D Badgaiyan, Abdalla Bowirrat
Publikováno v:
Curr Psychopharmacol
Neuroscientists and psychiatrists working in the areas of “pain and addiction” are asked in this perspective article to reconsider the current use of dopaminergic blockade (like chronic opioid agonist therapy), and instead to consider induction o
Autor:
Edward J. Modestino, Brent Boyett, William B. Downs, James Giordano, David Baron, Panayotis K. Thanos, Marjorie C. Gondré-Lewis, Kenneth Blum, Steinberg Bruce, Lyle Fried, Rajendra D. Badgaiyan, Lisa Lott, Eric R. Braverman, David Siwicki, Jessica Valdez Ponce
Publikováno v:
Current Pharmaceutical Biotechnology. 21:528-541
Background/Aims:This case series presents the novel Genetic Addiction Risk Score (GARS®) coupled with a customized pro-dopamine regulator matched to polymorphic reward genes having a hypodopaminergic risk.Methods:The proband is a female with a histo
Autor:
Lisa Lott, Brent Boyett, Jessica Valdez Ponce, Bruce Steinberg, Kenneth Blum, Mary Hauser, Thomas Simpatico, Downs Bw, Edward J Modestino, Rajendra D Badgaiyan, David Siwicki, Lyle Fried, Thomas J. McLaughlin, Raju Hajela, David Baron
Publikováno v:
Current Psychopharmacology. 9:7-21
Background: The search for an accurate, gene-based test to identify heritable risk factors for Reward Deficiency Syndrome (RDS) was conducted based on hundreds of published studies about the role of dopamine in addictive behaviors, including risk for
Autor:
Ashim Gupta, Abdalla Bowirrat, Luis Llanos Gomez, David Baron, Igor Elman, John Giordano, Rehan Jalali, Rajendra D. Badgaiyan, Edward J. Modestino, Mark S. Gold, Eric R. Braverman, Anish Bajaj, Kenneth Blum
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 19, Iss 552, p 552 (2022)
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health
In the United States, amid the opioid overdose epidemic, nonaddicting/nonpharmacological proven strategies are available to treat pain and manage chronic pain effectively without opioids. Evidence supporting the long-term use of opioids for pain is l